A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Donna Skerrett, Vinod K. Prasad et al.|Transplantation and Cellular Therapy|2020Cited by 201
A Phase 3 Single-Arm, Prospective Study of Remestemcel-L, Ex-Vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Steroid Refractory Acute Gvhd in Pediatric PatientsSonali Chaudhury, Joanne Kurtzberg, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2018Cited by 8
Effect of Human Mesenchymal Stem Cells (Remestemcel-L) on Clinical Response and Survival Confirmed in a Large Cohort of Pediatric Patients with Severe High-Risk Steroid-Refractory Acute Graft Versus Host DiseaseJoanne Kurtzberg, Donna Skerrett, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2016Cited by 3
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host DiseaseJoanne Kurtzberg, Donna Skerrett, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2015Cited by 1